HLA-DR1–Restricted bcr-abl (b3a2)-Specific CD4+ T Lymphocytes Respond to Dendritic Cells...

Preferentially expressed antigen of melanoma (PRAME) in the development of diagnostic and therapeutic methods for hematological malignancies

M Matsushita, R Yamazaki, H Ikeda… - Leukemia & …, 2003 - Taylor & Francis

PRAME (Preferentially expressed antigen of melanoma), highly expressed in various solid
tumor cells and normal testis, was first isolated as a human melanoma antigen recognized …

被引用次数：67 相关文章所有 9 个版本

Novel targeted and immunotherapeutic strategies in chronic myeloid leukemia

J Schwartz, J Pinilla-Ibarz, RR Yuan… - Seminars in …, 2003 - Elsevier

The advanced understanding of the molecular biology and immunology of chronic myeloid
leukemia (CML) has led to novel therapeutic strategies unique to this disease. CML …

被引用次数：50 相关文章所有 6 个版本

[HTML] nih.gov

The abl/bcr gene product as a novel leukemia-specific antigen: peptides spanning the fusion region of abl/bcr can be recognized by both CD4⁺ and CD8⁺ T …

WM Wagner, Q Ouyang, G Pawelec - Cancer Immunology …, 2003 - Springer

Chronic myelogenous leukemia (CML) is characterized by a reciprocal translocation leading
to the Philadelphia chromosome. Two fusion genes are created by this translocation: bcr/abl …

被引用次数：45 相关文章所有 14 个版本

[PDF] researchgate.net

[PDF][PDF] Synthetic peptides derived from the Wilms' tumor 1 protein sensitize human T lymphocytes to recognize chronic myelogenous leukemia cells

L Müller, A Knights, G Pawelec - The Hematology Journal, 2003 - researchgate.net

The Wilms' tumour 1 (WT1) molecule was screened in silico for the presence of 15-mer
sequences predicted to bind HLA-DRB1* 0401 (www. syfpeithi. de). Two peptides with the …

被引用次数：38 相关文章所有 5 个版本

Immunization of Patients with Malignant Melanoma with Autologous CD34⁺ Cell-Derived Dendritic Cells Transduced Ex Vivo with a Recombinant Replication …

M Di Nicola, C Carlo-Stella, A Anichini… - Human gene …, 2003 - liebertpub.com

Study Design: Nonrandomized, noncontrolled, single center Study Objectives: Primary
objective: Define the safety and toxicity of DCs/MVA-hTyr vaccine in patients with …

被引用次数：32 相关文章所有 9 个版本

Role of CD4+ T lymphocytes in antitumor immunity

É Rajnavölgyi, Á Lányi - Advances in cancer research, 2003 - Elsevier

Publisher Summary This chapter discusses the role of CD4+ T lymphocytes in antitumor
immunity, which recognize peptides of exogenous proteins in the context of major …

被引用次数：17 相关文章所有 5 个版本

蛋白转导域介导BCR/ABL 抗原对CML 患者T 细胞的活化作用

刘强，梁英民，郑瑾，李学义，陈任安，蒋姗姗… - 细胞与分子免疫学 …, 2003 - cqvip.com

目的: 研究蛋白转导域(PTD) 介导的BCR/ABL 抗原对慢性髓细胞白血病(CML) 患者T
细胞的特异性活化作用. 方法: 利用基因工程技术, 将PTD 基因与CML b3a2 bcr/abl …

被引用次数：4 相关文章所有 4 个版本